69 results
·
16ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 3
×
Tissue Adhesive For Use In Embolization Of Brain Arteriovenous Malformations
FDA Pre-Market Approval
FDA Class 3
·TRUFILL N-BUTYL CYANOACRYLATE (NBCA) LIQUID EMBOLIC SYSTEM
Tissue Adhesive For Use In Embolization Of Brain Arteriovenous Malformations
FDA Pre-Market Approval
FDA Class 3
·TRUFILL N-BUTYL CYANOACRYLATE (N-BCA) LIQUID EMBOLIC SYSTEM
Tissue Adhesive For Use In Embolization Of Brain Arteriovenous Malformations
FDA Pre-Market Approval
FDA Class 3
·TRUFILL N-BUTYL CYANOACRYLATE LIQUID EMBOLIC SYSTEM
Tissue Adhesive For Use In Embolization Of Brain Arteriovenous Malformations
FDA Pre-Market Approval
FDA Class 3
·TRUFILL n-Butyl Cyanoacrylate (n-BCA) Liquid Embolic System
Tissue Adhesive For Use In Embolization Of Brain Arteriovenous Malformations
FDA Pre-Market Approval
FDA Class 3
·TRUFILL N-BUTYL CYANOACRYLATE (N-BCA) LIQUID EMBOLIC SYSTEM
Tissue Adhesive For Use In Embolization Of Brain Arteriovenous Malformations
FDA Pre-Market Approval
FDA Class 3
·TRUFILL N-BUTYL CYANOACRYLATE (N-BCA) LIQUID EMBOLIC SYSTEM.
Tissue Adhesive For Use In Embolization Of Brain Arteriovenous Malformations
FDA Pre-Market Approval
FDA Class 3
·TRUFILL N-BUTYL CYANOACRYLATE (N-BCA) LIQUID EMBOLIC SYSTEM
System, Laser, Fiber Optic, Photodynamic Therapy
FDA Pre-Market Approval
FDA Class 3
·OPTIGUIDE FIBER OPTIC DIFFUSER (DCYL CYLINDRICAL DIFFUSER SERIES)
Assay,Enzyme Linked Immunosorbent,Parvovirus B19 Igg
FDA classification
FDA Class 3
·Assay,Enzyme Linked Immunosorbent,Parvovirus B19 Igg